How should hypertrophic cardiomyopathy be classified?: Molecular diagnosis for hypertrophic cardiomyopathy: Not ready for prime time.

@article{Elliott2009HowSH,
  title={How should hypertrophic cardiomyopathy be classified?: Molecular diagnosis for hypertrophic cardiomyopathy: Not ready for prime time.},
  author={Perry M Elliott and William J. McKenna},
  journal={Circulation. Cardiovascular genetics},
  year={2009},
  volume={2 1},
  pages={87-9; discussion 89}
}
Fifty years ago, Donald Teare,1 a well-known forensic pathologist in London, reported 8 cases of “asymmetrical hypertrophy or benign tumor” of the heart. Each had disproportionate hypertrophy of the interventricular septum, a coarse myocardial texture, and a bizarre arrangement of muscle fibers, separated by excessive connective tissue and clefts. At the time, numerous names for this entity were proposed, but after a relatively short period, the term hypertrophic cardiomyopathy (HCM) was… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 13 references

Report of the WHO / ISFC task force on the definition and classification of cardiomyopathies

P Richardson, W McKenna, +6 authors J Goodwin
Br Heart J • 1972

Similar Papers

Loading similar papers…